Search research articles
Contact Us
Filters
Showing results (141-150 of 529) with videos related to
Page
of 53
Sort By:
Medizinische Klinik (Munich, Germany : 1983)
|
December 30, 2009
[Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008]
Mario Thevis, Peter Hemmersbach, Hans Geyer, et al.
Rapid Communications in Mass Spectrometry : RCM
|
October 20, 2006
Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes
Mario Thevis, Frauke Wilkens, Hans Geyer, et al.
Journal of Chromatography. A
|
January 22, 2013
Ultrahigh pressure liquid chromatography-(tandem) mass spectrometry in human sports drug testing: possibilities and limitations
Mario Thevis, Andreas Thomas, Valentin Pop, et al.
Drug Testing and Analysis
|
November 29, 2013
Annual banned-substance review: analytical approaches in human sports drug testing
Mario Thevis, Tiia Kuuranne, Hans Geyer, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
November 19, 2013
Mass spectrometric studies on the in vivo metabolism and excretion of SIRT1 activating drugs in rat urine, dried blood spots, and plasma samples for doping control purposes
Sebastian Höppner, Philippe Delahaut, Wilhelm Schänzer, et al.
Analytical and Bioanalytical Chemistry
|
April 18, 2020
Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS
Tobias Lange, Andreas Thomas, Katja Walpurgis, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 27, 2012
Synthesis, mass spectrometric characterization, and analysis of the PPARδ agonist GW1516 and its major human metabolites: targets in sports drug testing
Mario Thevis, Ines Möller, Simon Beuck, et al.
Analytical Science Advances
|
May 8, 2024
Probing for peptidic drugs (2-10 kDa) in doping control blood samples
Andreas Thomas, Sam Thilmany, Amelie Hofmann, et al.
Drug Testing and Analysis
|
May 4, 2011
Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet
Mario Thevis, Hans Geyer, Andreas Thomas, et al.
Rapid Communications in Mass Spectrometry : RCM
|
May 23, 2009
Determination of the deuterium/hydrogen ratio of endogenous urinary steroids for doping control purposes
Thomas Piper, Mario Thevis, Ulrich Flenker, et al.
Page
of 53
Search research articles
Search
Showing results (141-150 of 529) with videos related to
Sort By:
Page
of 53
Medizinische Klinik (Munich, Germany : 1983)
|
December 30, 2009
[Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008]
Mario Thevis, Peter Hemmersbach, Hans Geyer, et al.
Rapid Communications in Mass Spectrometry : RCM
|
October 20, 2006
Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes
Mario Thevis, Frauke Wilkens, Hans Geyer, et al.
Journal of Chromatography. A
|
January 22, 2013
Ultrahigh pressure liquid chromatography-(tandem) mass spectrometry in human sports drug testing: possibilities and limitations
Mario Thevis, Andreas Thomas, Valentin Pop, et al.
Drug Testing and Analysis
|
November 29, 2013
Annual banned-substance review: analytical approaches in human sports drug testing
Mario Thevis, Tiia Kuuranne, Hans Geyer, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
November 19, 2013
Mass spectrometric studies on the in vivo metabolism and excretion of SIRT1 activating drugs in rat urine, dried blood spots, and plasma samples for doping control purposes
Sebastian Höppner, Philippe Delahaut, Wilhelm Schänzer, et al.
Analytical and Bioanalytical Chemistry
|
April 18, 2020
Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS
Tobias Lange, Andreas Thomas, Katja Walpurgis, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 27, 2012
Synthesis, mass spectrometric characterization, and analysis of the PPARδ agonist GW1516 and its major human metabolites: targets in sports drug testing
Mario Thevis, Ines Möller, Simon Beuck, et al.
Analytical Science Advances
|
May 8, 2024
Probing for peptidic drugs (2-10 kDa) in doping control blood samples
Andreas Thomas, Sam Thilmany, Amelie Hofmann, et al.
Drug Testing and Analysis
|
May 4, 2011
Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet
Mario Thevis, Hans Geyer, Andreas Thomas, et al.
Rapid Communications in Mass Spectrometry : RCM
|
May 23, 2009
Determination of the deuterium/hydrogen ratio of endogenous urinary steroids for doping control purposes
Thomas Piper, Mario Thevis, Ulrich Flenker, et al.
Page
of 53